Our Commitment. Our Promise.
Merit Medical is committed to reducing the burden that cancer places on patients and their loved ones. To further demonstrate this commitment, Merit is partnering with BreastCancer.org, an organization dedicated to educating and empowering people with breast cancer.
Throughout the months of September and October 2020, Merit will donate $1,000 to Breastcancer.org for each SCOUT® console sold worldwide that exceeds monthly goals. Learn more about SCOUT Radar Localization.
Like Merit, BreastCancer.org is committed to the mission of reducing the burden of breast cancer and reaches millions of people each month worldwide, providing much-needed resources and support.
During Breast Cancer Awareness Month and every month, Merit’s promise remains the same—to consistently invest in improving technologies and innovating new platforms that meet patient and physician needs.
Prelude IDeal™ Provides Real Solution to Common Radial Access Challenge
Prelude IDeal™ Provides Real Solution to Common Radial Access Challenge
During radial access procedures, many thin-walled sheath introducers on the market pose the risk of kinking or compressing, either near the access site or inside the radial artery, resulting in wires, catheters, and other devices unable to move through. After years of research, the Merit R&D team built the Prelude IDeal™, a hydrophilic sheath introducer designed to specifically resist kinking and compression while also facilitate smooth device movement and exchange, providing a real solution to this common radial access challenge.
THINNER BUT STRONGER
To combat both kinking and compression, the Merit R&D team envisioned a sheath with a wall that was thinner and stronger than the products physicians currently used.
To achieve this balance, they developed a composite braiding technology to serve as the inner layer of the Prelude IDeal sheath, giving it a 13% thinner wall than the leading thin-walled sheath competitor.1 Unlike other thin-walled sheaths, the braiding of the Prelude IDeal also gives it structural integrity to increase kinking and compression resistance, making it 124% more resistant to sidewall compression and 23% more kink resistant than the leading competitor.1
SAME OD, LARGER ID
With a thinner wall, the Prelude IDeal maintains the same sheath outer diameter (OD) as the market leader but larger inner diameter (ID). This increased internal capacity enables smooth wire, catheter, and device manipulation and exchange.
MADE FOR RADIAL
The Prelude IDeal was developed specifically with radial access in mind. Combining a thinner wall with a composite braiding technology enable the Prelude IDeal to maintain structural integrity, protecting the sheath from compression during vessel spasm, a potential side effect of radial artery access.
In addition, the Prelude IDeal’s kink resistance is crucial when implementing the distal radial technique, where the anatomy of the hand can be more tortuous and accessing the vessel at an increased upright angle is necessary. The robust structure of the Prelude IDeal makes it a practical device choice in distal radial procedures.
WITHSTANDS EXTERNAL PRESSURE
A typical thin-walled sheath may collapse, for example, when it encounters a narrowing of the vessel, preventing catheters and wires from passing through.
With structural integrity provided by its braided composite structure, the Prelude IDeal withstands the natural bends and curves of the artery and aids in straightening the vessel, allowing catheter manipulation and torque without sheath compression.
DISCOVER THE PELUDE IDEAL
The Prelude IDeal Hydrophilic Sheath Introducer has become the tool of choice for radial and distal radial access procedures around the globe. Its story is much like Merit’s overall goal—to listen to the needs of physicians and innovate ways to improve patient care.
Explore all the Prelude IDeal has to offer by visiting its product page or contacting the Merit Customer Support Center.
- 6F Data on File. Merit assumes no responsibility to update test data.
Now Available in the US, Surfacer® System Provides Treatment Option for Venous Obstructions
Merit Medical® is committed to offering products that provide patients with better dialysis access options. The newest of these innovations is the Surfacer® Inside-Out® Access Catheter System, a unique device designed to obtain right-sided central venous access in patients with venous obstructions. The Surfacer System received FDA De Novo classification in the US earlier this year and has been CE marked in Europe since 2016.
The current clinical approach when treating dialysis patients with chronically occluded central veins is to use another vein if a subsequent central venous catheter is needed. Failed venous access attempts may prevent permanent arteriovenous access, increasing patient morbidity and the overall cost of care.1
Designed to gain central venous access, the Surfacer System works by inserting the device through the right femoral vein and navigating it up through the patient’s venous system with an exit point in the right internal jugular vein, the optimal location for placing a central venous catheter. Watch how the Surfacer System works.
This proprietary “Inside-Out” approach supports the achievement of permanent arteriovenous access, which reduces hemodialysis provider cost and patient downtime by decreasing catheter-related morbidity and complications.1
Additional clinical benefits of using the Surfacer System were seen in its first-in-human study.2 Results showed that 100% of patients experienced successful central venous access placement, and 100% of patients maintained central venous access patency through long-term follow up. No device-related adverse events were reported at short- or long-term follow up. To learn more about the Surfacer System’s first-in-human study, view the article published in Endovascular Today.
In May of this year, the Surfacer System’s first US-based commercial cases were completed at Santa Clara Valley Medical Center in San Jose, California, one of several clinical sites for the US investigational device exemption (IDE) study, which led to FDA De Novo status. Ehab Sorial, MD, and Ajit Nair, MD, performed the procedures in two hemodialysis patients with central venous obstructions, one of which had limited access options.
“The Surfacer System provides us with a safe and effective option for obtaining right-sided central venous access in patients with venous obstructions, enabling us to preserve secondary central veins and avoid alternative access procedures, which are not as effective and have a higher risk of complications,” explained Drs. Sorial and Nair in a press release. Read the full press release here.
Merit currently distributes the Surfacer System in North America and Europe. With the device’s recent launch in the US, Merit is proud to play an integral role in providing physicians with life-saving technologies for their patients around the world.
Discover the Surfacer Inside-Out Access Catheter System and explore Merit’s entire portfolio of renal therapies and accessories.
All trademarks are property of their respective owners.
- Data on file at Bluegrass Vascular Technologies, Inc.
- Ebner, A., S. Gallo, C. Cetraro, J. Gurley, and L. Minarsch. 2013. “Inside-Out Upper Body Venous Access: The First-in-Human Experiences with a novel Approach Using the Surfacer Inside-Out Access Catheter System.” Endovascular Today. June 2013. https://evtoday.com/articles/2013-june/inside-out-upper-body-venous-access.